Back

First-in-human trial of PCSK9 gene editing therapy for lowering cholesterol: a new frontier in cardiovascular pharmacotherapy? News from AHA

European Heart Journal - Cardiovascular Pharmacotherapy

29 November 2023
Organised by: Logo
Read full article
ESC Journals

Contributors

Basil S Lewis
Basil S Lewis

Author

Technion - Israel Institute of Technology Haifa , Israel

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources